Skip to search formSkip to main contentSkip to account menu

Drug Recalls

Known as: Recalls, Drug, drugs recall, drugs recalled 
Removal of a drug from the market due to a problem occurring in the manufacture or distribution of the product.
National Institutes of Health

Related topics

Related topics

3 relations
Legislation, DrugSafety-Based Drug Withdrawalslegislation & jurisprudence

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
How quality control could save your science
It may not be sexy, but quality assurance is becoming a crucial part of lab life. 
2013
2013
The smartest, greenest grid
What a little Danish island is showing the world about the future of energy. On Christmas night, Maja Bendtsen and her husband… 
2010
2010
How green biotech turned white and blue
Argentina has blazed a trail as one of the leading genetically modified (GM) crop producers. Can other developing countries… 
2009
2009
Banning cluster munitions.
In 2003, in the immediate aftermath of the invasion of Iraq by coalition forces, Dr Jean-Baptiste Richardier, Director-General… 
2009
2009
Exploring the Beliefs Underlying Attitudes to Active Voluntary Euthanasia in a Sample of Australian Medical Practitioners and Nurses: A Qualitative Analysis
A qualitative study explored beliefs about active voluntary euthanasia (AVE) in a sample (N = 18) of medical practitioners and… 
2009
2009
Amphibian decline. Life and death play out on the skins of frogs.
Amphibian DeclineOn page [582][1] of this week's issue of Science , researchers go a long way toward solving the mystery of how a… 
2008
2008
Using accelerometer feedback to identify walking destinations, activity overestimates, and stealth exercise in obese and nonobese individuals.
BACKGROUND Accelerometer output feedback might enable assessment of recall biases for moderate bouts by obese and nonobese… 
2008
2008
17q21.31: Not Your Average Genomic Address
This region of chromosome 17 has had a storied history, with changes in its DNA of import to human evolution and disease. 
2002
2002
High rates of adverse effects and patient unawareness of withdrawn lipid‐lowering drug combination in a public hospital clinic
Examine use, patient awareness and outcomes of concurrent cerivastatin and gemfibrozil in a public hospital clinic system 2 weeks… 
Review
1998
Review
1998
Is the FDA approving drugs too fast?
Debate in the United States about the optimal amount of time required by the Food and Drug Administration for adequate testing of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)